Coronary Artery Bypass Graft Surgery

In the FAME 3 trial, PCI guided by fractional flow reserve failed to meet noninferiority for reduction of MACCE at 1 year compared with CABG in patients with three-vessel CAD.

According to an analysis in JACC: Cardiovascular Interventions, the results of the ISCHEMIA trial of invasive vs. conservative treatment of stable ischemic heart disease may only be applicable to one-third of the real-world PCI population.

Among patients undergoing CABG, the no-touch technique for vein harvesting reduced risk for vein graft occlusion and improved patient prognosis compared with the conventional harvesting technique, according to new research in Circulation.

Like other specialties in medicine, cardiology has seen an influx in interest in less invasive therapeutic options.

At 10 years, patients with three-vessel or left main disease who underwent PCI or CABG were more likely to survive if they were taking optimal medical therapy at 5 years, researchers reported.

The use of CABG has declined dramatically in MI admissions, particularly in STEMI, according to a presentation at the American College of Cardiology Scientific Session.

Intraoperative transesophageal echocardiography during CABG was associated with lower odds of 30-day mortality, particularly among higher-risk patients, a speaker reported.

LivaNova announced it received FDA 510(k) clearance for its system for monitoring arterial and venous blood gas parameters during pediatric and adult CABG procedures.

Researchers at the Kaiser Permanente Health System observed that a single troponin test at ED admission for patients with suspected ACS may be enough to rule out acute MI and reduce hospital stay.

Among patients who underwent CABG, women were less likely than men to have procedures performed according to guideline recommendations, researchers reported at the virtual Society of Thoracic Surgeons Annual Meeting.